DataCloudKnowledgetrainingcoordination

L1000 LINCS DCIC FIBR020 MCLF135CN 6H C18 levothyroxine 0.04uM.tsv.gz (File)

Taxon:

Homo sapiens

Taxon (Entity type)

Subject:

MCLF135CN

Subject (Entity type)

Project:

LINCS-2021

Project (Entity type)

File Format:

TSV

File Format (Entity type)

Dcc Asset:

datapackage.zip

Processed File (Entity type)

Dcc:

LINCS

DCC (Entity type)

Data Type:

gene expression profile

Data Type (Entity type)

Compression Format:

GZIP format

File Format (Entity type)

Biosample:

L1000 LINCS DCIC 2021 FIBR020 MCLF135CN 6H C18 levothyroxine 0.04uM

Biosample (Entity type)

Assay Type:

landmark transcript profiling assay

Assay Type (Entity type)

Uncompressed Size In Bytes:311 KB

Size In Bytes:131 KB

Sha256:e12d959db91e3874efe72f3f31c395918d573eb7913b6682e2f2f0383c0d882e

Persistent Id:drs://drs.lincs-dcic.org/0fa483c073f803fcbd36fe86d56eb3a3

Mime Type:application/gzip

Md5:0fa483c073f803fcbd36fe86d56eb3a3

Filename:L1000_LINCS_DCIC_FIBR020_MCLF135CN_6H_C18_levothyroxine_0.04uM.tsv.gz

Creation Time:2021-01-21T00:00:00

Access Url:

drs://drs.lincs-dcic.org/0fa483c073f803fcbd36fe86d56eb3a3

Results found

Linked to

	Label	Description
	L1000 LINCS DCIC 2021 FIBR020 MCLF135CN 6H C18 levothyroxine 0.04uM Biosample (Entity type)	A biosample from LINCS produced as part of the LINCS 2021 project

L1000 LINCS DCIC 2021 FIBR020 MCLF135CN 6H C18 levothyroxine 0.04uM

Biosample (Entity type)

A biosample from LINCS produced as part of the LINCS 2021 project

DISPLAY PER PAGE

Consortium

Community

Resources

@CFDE Workbench 2026

The CFDE Workbench is actively being developed and maintained by the CFDE Data Resource Center (DRC).The DRC is funded by OT2OD036435 from the Common Fund at the National Institutes of Health.

Consortium

Community

Resources

The CFDE Workbench is actively being developed and maintained by the CFDE Data Resource Center (DRC).The DRC is funded by OT2OD036435 from the Common Fund at the National Institutes of Health.

@CFDE Workbench 2026

This repository is under review for potential modification in compliance with Administration directives.